Sign in

CIK 0001637715

  • Emerging growth company

OnKure Therapeutics, Inc.

Sign in to watch
Ticker
OKUR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472309515
Phone
+1 720-307-2892
Business address
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
Former names
Reneo Pharmaceuticals, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,157
in 2 filings

Net −$1,157. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-21 Leverone Jason A. Chief Financial Officer Sale −302 $2.97 $898 18,500
2026-09-21 Saccomano Nicholas A President and CEO Sale −87 $2.97 $259 11,160
2026-08-07 Hartley Dylan Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2026-08-07 Hartley Dylan Chief Scientific Officer Returned to the company · Employee Stock Option (right to buy) −137,603 0
2026-08-07 Hartley Dylan Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +137,603 137,603
2026-08-07 Phillips Andrew John Director Grant or award · Stock Option (right to buy) +22,350 22,350
2026-08-07 Jansen Valerie Malyvanh Director Grant or award · Stock Option (right to buy) +22,350 22,350
2026-08-07 Agresta Samuel Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2026-08-07 Agresta Samuel Chief Medical Officer Returned to the company · Employee Stock Option (right to buy) −18,588 0
2026-08-07 Agresta Samuel Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +18,588 18,588
2026-08-07 Agresta Samuel Chief Medical Officer Returned to the company · Employee Stock Option (right to buy) −131,396 0
2026-08-07 Agresta Samuel Chief Medical Officer Grant or award · Employee Stock Option (right to buy) +131,396 131,396
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +50,000 50,000
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy −5,781 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy +5,781 5,781
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −5,322 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +5,322 5,322
2026-08-07 Leverone Jason A. Chief Financial Officer Returned to the company · Employee Stock Option (right to buy) −130,611 0
2026-08-07 Leverone Jason A. Chief Financial Officer Grant or award · Employee Stock Option (right to buy) +130,611 130,611
2026-08-07 Carruthers R Michael Director Grant or award · Stock Option (right to buy) +22,350 22,350

Page 1 of 11 · 214 trades